Profile data is unavailable for this security.
About the company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.
- Revenue in HKD (TTM)6.56bn
- Net income in HKD-745.99m
- Incorporated2015
- Employees6.94k
- LocationGenscript Biotech CorpNo. 28Yongxi Road, Jiangning Science ParkNANJING ChinaCHN
- Phone+86 2 558897288
- Fax+86 2 558897288
- Websitehttps://www.genscript.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luye Pharma Group Ltd | 6.63bn | 574.84m | 10.72bn | 5.27k | 18.56 | 0.7927 | 8.00 | 1.62 | 0.1536 | 0.1536 | 1.78 | 3.60 | 0.247 | 2.42 | 3.60 | 1,258,095.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
SciClone Pharmaceuticals (Holdings) Ltd | 3.41bn | 1.21bn | 11.68bn | 1.05k | 9.99 | 3.18 | 8.54 | 3.43 | 1.86 | 1.86 | 5.24 | 5.84 | 0.7585 | 3.56 | 3.83 | 3,243,639.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
SSY Group Ltd | 6.46bn | 1.32bn | 13.90bn | 5.60k | 10.57 | 2.00 | 7.95 | 2.15 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
Zai Lab Ltd | 2.27bn | -2.65bn | 14.66bn | 2.18k | -- | 2.42 | -- | 6.45 | -2.73 | -2.73 | 2.35 | 6.12 | 0.2697 | 2.84 | 5.61 | -- | -31.41 | -37.72 | -36.81 | -42.72 | 62.86 | 64.75 | -116.45 | -282.44 | 4.43 | -- | 0.0596 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
3SBio Inc | 8.44bn | 1.67bn | 15.51bn | 5.41k | 9.44 | 1.01 | 7.48 | 1.84 | 0.6739 | 0.6739 | 3.45 | 6.31 | 0.3426 | 1.58 | 7.01 | 1,558,983.00 | 6.95 | 7.44 | 9.03 | 9.29 | 84.98 | 82.91 | 20.30 | 21.50 | 2.26 | 22.72 | 0.2266 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
Simcere Pharmaceutical Group Ltd | 7.13bn | 771.43m | 16.08bn | 7.03k | 21.29 | 2.07 | 14.55 | 2.25 | 0.2894 | 0.2894 | 2.73 | 2.98 | 0.6106 | 3.53 | 2.65 | 1,014,905.00 | 6.60 | 10.17 | 8.94 | 15.60 | 75.43 | 78.82 | 10.80 | 17.50 | 1.87 | 0.9742 | 0.1652 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
The United Laboratories Intl. Hldgs Ltd. | 14.83bn | 2.92bn | 16.48bn | 15.00k | 5.65 | 1.20 | 4.67 | 1.11 | 1.60 | 1.60 | 8.16 | 7.56 | 0.6871 | 3.36 | 6.15 | 988,620.40 | 13.51 | 7.89 | 20.52 | 12.64 | 46.11 | 44.17 | 19.66 | 12.73 | 1.74 | -- | 0.1055 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 14.67 |
Grand Pharmaceutical Group Ltd | 10.53bn | 1.88bn | 17.82bn | 10.53k | 9.37 | 1.16 | 7.79 | 1.69 | 0.5356 | 0.5356 | 3.00 | 4.33 | 0.4692 | 2.94 | 10.26 | 999,581.40 | 8.45 | 10.09 | 11.66 | 14.01 | 61.96 | 61.97 | 18.00 | 22.35 | 0.9819 | 22.96 | 0.1831 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
WuXi XDC Cayman Inc | 2.29bn | 306.02m | 19.04bn | 1.18k | 56.85 | 3.23 | 51.49 | 8.31 | 0.2797 | 0.2797 | 2.13 | 4.92 | -- | -- | -- | 1,945,872.00 | -- | -- | -- | -- | 26.35 | -- | 13.35 | -- | 4.03 | -- | 0.0005 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Genscript Biotech Corp | 6.56bn | -745.99m | 19.09bn | 6.94k | -- | 1.75 | -- | 2.91 | -0.3541 | -0.3541 | 3.11 | 5.13 | 0.283 | 7.59 | 5.45 | 945,580.50 | -11.97 | -18.34 | -18.27 | -26.15 | 48.78 | 54.68 | -42.30 | -64.91 | 4.65 | -- | 0.1694 | -- | 34.17 | 29.44 | 57.91 | -- | 17.14 | -- |
China Traditional Chinese Med Hldg CoLtd | 19.56bn | 1.39bn | 21.65bn | 17.30k | 15.61 | 0.9482 | 8.03 | 1.11 | 0.2755 | 0.2755 | 3.88 | 4.54 | 0.4985 | 1.47 | 2.16 | 1,130,367.00 | 3.84 | 4.60 | 5.85 | 7.07 | 51.18 | 57.07 | 7.70 | 9.77 | 1.48 | 9.83 | 0.1773 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
RemeGen Co Ltd | 1.16bn | -1.63bn | 23.06bn | 3.62k | -- | 3.70 | -- | 19.85 | -3.03 | -3.03 | 2.16 | 6.90 | 0.1864 | 0.4005 | 4.31 | 321,287.90 | -26.17 | -18.66 | -31.75 | -23.75 | 76.48 | 81.94 | -140.43 | -102.88 | 1.31 | -64.32 | 0.2682 | -- | 40.16 | 148.65 | -51.30 | -- | 59.07 | -- |
HUTCHMED (China) Ltd | 6.55bn | 787.42m | 25.62bn | 1.99k | 32.75 | 4.49 | 29.99 | 3.91 | 0.8978 | 0.8978 | 7.62 | 6.55 | 0.7258 | 7.19 | 7.69 | 3,293,530.00 | 8.76 | -14.35 | 13.36 | -20.43 | 54.12 | 36.57 | 12.06 | -31.44 | 2.60 | -- | 0.1038 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 09 May 2024 | 38.23m | 1.80% |
HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 35.54m | 1.67% |
BlackRock Fund Advisorsas of 09 May 2024 | 26.18m | 1.23% |
Norges Bank Investment Managementas of 31 Dec 2023 | 24.02m | 1.13% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 23.62m | 1.11% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 22.17m | 1.04% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 12.40m | 0.58% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 10.97m | 0.52% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 10.22m | 0.48% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 9.95m | 0.47% |